Jose Agurto Tello Hospital
Lima, 05001, Peru
NCT Number: NCT06282367
Background and Aims: The quality of colonoscopy is critically influenced by bowel preparation. Polyethylene glycol (PEG) is considered the gold standard regimen for bowel preparation, however due to the necessity of large volume of patient's tolerance is impaired, especially in the elderly population. Lactulose has been adopted in a few centers as a novel alternative for colonoscopy preparation. This study aimed to investigate the efficacy-safety profile of a lactulose-based bowel preparation in comparison to PEG for colonoscopy.
Methods: Prospective non-blinded comparative study, developed in two tertiary centers from July 2021 to April 2023. Outpatients undergoing colonoscopy were randomly divided into 2 groups: Group 1 (111 patients): PEG and Group 2 (111 patients): Lactulose. The following clinical outcomes were assessed for each group: degree of bowel clearance using the Boston Score, colorectal polyp detection rate, adenoma detection rate, tolerability and side effects.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Lima, 05001, Peru
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 21 month
minimum value: 0 (worse outcome: inadequate bowel preparation); maximum value: 9 (better outcome: adequate bowel preparation)
Time frame: 21 months
Josue Aliaga
Other Gov
Novel Regimen for Colonoscopy Bowel Preparation With Oral Lactulose: A Prospective Comparative Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06722209
Colonic Diseases, Colonoscopy
View Trial DetailsNCT06763705
Colonoscopy, Conscious Sedation
Unaizah, Al-Qassim Region, Saudi Arabia
View Trial DetailsNCT06407531
Colonoscopy
Antalya, Finike, Turkey (Türkiye)
View Trial DetailsNCT04921488
Colonic Diseases, Colonoscopy
Angers, France
View Trial Details